Axsome Therapeutics Stock Jumped: April Rally and What It Means for Investors
Axsome Therapeutics rode a powerful April rally driven by Auvelity performance and pipeline momentum. This article br...
We examine altcoins with strong funding, evaluating how capital enables development pace, partnerships, and long-term roadmap execution.
17,339 articlesAxsome Therapeutics rode a powerful April rally driven by Auvelity performance and pipeline momentum. This article br...
Warren Buffett’s latest move at Berkshire Hathaway signals a rare, hands-on embrace of a mega-stock. This piece break...
As the 10-year yield hovers near 4.4%, many investors chase top-yield REITs for income. The real cost chasing reit be...
NAR released its Q2 update to the 2026-2028 strategic plan, detailing progress across seven priority areas including ...
EDIV has outperformed on yield-focused EM plays, but the next year hinges on the dollar’s next move will drive curren...
blockbuster numbers aren’t just hoopla. when avengers: doomsday racks up $16.5m in first-day presales, it highlights...
Chip stocks are rising on AI infrastructure strength even as software names sag, hinting at a broader market rotation...
A famed market forecaster is signaling a bold by-year-end target for the S&P 500, driven by resilient earnings and a ...
Ripple Prime gains a $200 million asset-based debt facility to push broader margin lending for institutions, signalin...
Poppi’s journey shows how founders turn personal risk into billion-dollar exits. The cofounder maxed credit and even ...
Circle Internet Group posted a stronger-than-expected Q1 2026, triggering a 68% year-to-date gain and a rally that ou...
ZoomInfo's go-to-market approach is evolving as 2026 unfolds. This analysis breaks down the GTM moves behind the earn...